Wolverine Asset Management »

Travere Therapeutics shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $30M 45M 0.66
2023-09-30 $29M 45M 0.65
2023-06-30 $37M 45M 0.81
2023-03-31 $37M 38M 0.98
2022-12-31 $35M 38M 0.91
2022-09-30 $39M 38M 1.02
2022-06-30 $37M 37M 1.01
2022-03-31 $36M 34M 1.07

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Travere Therapeutics

Context Capital Management
Wolverine Asset Management
D. E. Shaw & Co
Highbridge Capital Management
Lazard Asset Management
Citigroup
Aviva
Capstone Investment Advisors
Braidwell
Segantii Capital Management
Jane Street
Readystate Asset Management
Point72 Asset Management
Lion Point Capital
Nomura Holdings

View all funds holding Travere Therapeutics